Cardiac mural cells are rate-limiting for coronary vascularization after heart injury

Zhengkai Lu1,2, Jian Zhou3, Min Ye2

  • 1State Key Laboratory of Cardiology and Medical Innovation Center, Shanghai East Hospital, School of Life Science and Technology, Frontier Science Center for Stem Cell Research, Tongji University, Shanghai 200092, China.

Iscience
|October 10, 2025
PubMed

Insights

Restricted vascularization after myocardial infarction (MI) is linked to mural cell coverage issues. Deleting phosphatase and tensin homolog (PTEN) in mural cells improves coronary vascularization and cardiac function post-MI.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Limited angiogenic potential of coronary vascular endothelial cells (cVECs) hinders therapeutic revascularization post-myocardial infarction (MI).
  • Mechanisms underlying restricted coronary vascularization after MI are not fully understood.
  • Inadequate mural cell coverage of coronary vessels impedes vascularization in the MI heart.

Purpose of the Study:

  • To investigate the role of mural cells in coronary vascularization post-MI.
  • To explore the function of phosphatase and tensin homolog (PTEN) in cardiac mural cells.
  • To identify therapeutic targets for enhancing angiogenesis and cardiac repair after ischemic injury.

Main Methods:

  • Conditional deletion of the Pten gene in cardiac mural cells.
  • Assessment of mural cell proliferation, coronary vascular density, and arteriogenesis.
  • Evaluation of cardiac function and chemokine expression (CXCL12) post-MI.

Main Results:

  • Conditional Pten deletion in mural cells enhanced mural-derived cell (MDC) proliferation and coronary vascular density.
  • Pten deficiency promoted arteriogenesis and improved cardiac function following MI.
  • Pten deficiency upregulated chemokine C-X-C motif ligand 12, potentially reducing apoptosis and increasing vascular density.

Conclusions:

  • Cardiac mural cells are critical for coronary vascular remodeling after MI.
  • Phosphatase and tensin homolog (PTEN) acts as an inhibitor of mural cell proliferation and vascularization.
  • Targeting cardiac mural cells, specifically by modulating PTEN, offers a promising therapeutic strategy for ischemic heart disease.